International General Insurance Holdings enters the week after a fresh earnings miss — Q1 adj. EPS came in at $0.56, well short of the $0.70 estimate. Revenue of $111.2 million also fell below the $128.2 million consensus. Yet the stock closed up nearly 1% on May 5, the day of the print, and has recovered ground after a 5.4% slide over the week. That gap between the headline miss and the muted price reaction is the most interesting tension around this name right now.
The earnings shortfall had a clear culprit. About $15 million of net losses tied to Middle East conflict — primarily political violence and an energy loss in the Persian Gulf — landed in the quarter, contributing 19.2 combined-ratio points of catastrophe losses. Strip those out and the underlying picture looks considerably better: underwriting income still came in at $37.7 million, up 35% year-over-year, and the combined ratio of 89.1% was 5.3 points better than Q1 2025. Core ROE held at 14.3%. Management noted on the Q1 call that the insured market loss from the Middle East conflict is already being estimated above €3 billion — and IGI's Jordan origins mean the region is no stranger territory. Book value per share slipped to $15.60, but that includes nearly $65 million returned to shareholders in the quarter: a $1.15 special dividend paid in April plus $13.1 million in buybacks. The extraordinary dividend — the largest payout in recent company history — appears to have set a high bar the market won't easily forget.
Short interest is minimal and tells no meaningful story here. SI stands at just 0.43% of the free float, down about 15% over the past month as the prior cluster of shorts around the 215,000-share level in early April has almost fully unwound. Cost to borrow has drifted higher — up roughly 37% on the week to 0.86% — but at sub-1% that reflects no real squeeze pressure. Borrow availability remains loose, and the ORTEX short score of 34.6 (43rd percentile) is firmly in neutral territory. Options positioning tilts bullish: the put/call ratio is running at 0.11, well below its 20-day average of 0.13, placing it near the low end of the past year's range. None of these signals suggest the market is positioning for further downside.
The analyst community is constructive, though the most recent formal updates date back to early 2025 and should be treated with some caution given the intervening period. RBC Capital reinstated coverage in December with an Outperform and a $28 target; Oppenheimer has an Outperform with a $32 target from February 2025. The mean price target of $32 implies more than 27% upside to the current $25.12 close — but note these estimates predate both the Middle East loss wave and the special dividend payment that reduced book value. The EPS surprise factor score of 68 (out of 100) reflects a history of beating estimates, making this quarter's miss somewhat anomalous.
Ownership is heavily concentrated and insider-aligned. Wasef Jabsheh — Executive Chairman and the voice of discipline on Tuesday's earnings call — holds 34.7% of shares. His son Waleed, the CEO, holds a further 1.6% and added 40,000 shares as recently as March. Hatem Jabsheh added 21,000 shares in the same period. The Jabsheh family collectively controls over 38% of the company. That concentration both limits float and anchors the long-term capital-return message: the special $1.15 dividend declared in February was the clearest recent signal of management confidence in the balance sheet. Diamond Hill Capital also added 125,540 shares in Q1 2026, making them a notable incremental buyer.
Among correlated peers, the week was broadly soft for the sector. CNA fell 8.6% and MKL dropped 7.6%, while HG lost 6.5%. Against that backdrop, IGIC's 5.4% decline looks relatively contained. BOW bucked the trend with a 3% weekly gain and 7.7% on Tuesday alone, suggesting name-specific catalysts are driving dispersion rather than any uniform sector move.
With Q2 now underway and the next scheduled report not until mid-August, the key watch item is how Middle East conflict losses develop through the remainder of the year. Management was explicit on the call about insured loss estimates crossing the €3 billion mark — how much of that ultimately flows to IGI's short-tail and reinsurance books will shape whether this quarter's miss is a speed bump or the start of a tighter earnings trajectory.
See the live data behind this article on ORTEX.
Open IGIC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
